Evaluation of a TNFR2 antibody with and without anti-PD-1 therapy in two murine colon cancer models

被引：0
|
作者：
Case, Katie [1 ]
Tran, Lisa [1 ]
Zheng, Hui [1 ]
Yang, Michael [1 ]
Faustman, Denise [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Charlestown, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P479
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effect of anti-PD-1 antibody, nivolumab on early gastric cancer
    Koji Fukuda
    Taichi Yoshida
    Kazuhiro Shimazu
    Daiki Taguchi
    Masahiro Inoue
    Hiroshi Nanjyo
    Hiroyuki Shibata
    International Cancer Conference Journal, 2017, 6 (3) : 98 - 103
  • [22] Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer
    Kobayashi, Kunihiko
    Kaira, Kyoichi
    Kagamu, Hiroshi
    ANTICANCER RESEARCH, 2020, 40 (09) : 5309 - 5311
  • [23] Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
    Topalian, Suzanne L.
    Hodi, F. Stephen
    Brahmer, Julie R.
    Gettinger, Scott N.
    Smith, David C.
    McDermott, David F.
    Powderly, John D.
    Carvajal, Richard D.
    Sosman, Jeffrey A.
    Atkins, Michael B.
    Leming, Philip D.
    Spigel, David R.
    Antonia, Scott J.
    Horn, Leora
    Drake, Charles G.
    Pardoll, Drew M.
    Chen, Lieping
    Sharfman, William H.
    Anders, Robert A.
    Taube, Janis M.
    McMiller, Tracee L.
    Xu, Haiying
    Korman, Alan J.
    Jure-Kunkel, Maria
    Agrawal, Shruti
    McDonald, Daniel
    Kollia, Georgia D.
    Gupta, Ashok
    Wigginton, Jon M.
    Sznol, Mario
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26): : 2443 - 2454
  • [24] Combination therapy with anti-PD-1 or PD-1 antibody alone in pediatric patients with relapsed or refractory cancer.
    Que, Yi
    Wang, Juan
    Zhu, Jia
    Li, Na
    Huang, Junting
    Lu, Suying
    Sun, Feifei
    Zhang, Lian
    Zhen, Zijun
    Zhang, Li
    Cai, Ruiqing
    Guo, Haixia
    Sun, Xiaofei
    Zhang, Yizhuo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory Cancer
    Que, Yi
    Wang, Juan
    Zhu, Jia
    Li, Na
    Huang, Junting
    Lu, Suying
    Sun, Feifei
    Zhang, Lian
    Zhen, Zijun
    Zhang, Li
    Cai, Ruiqing
    Guo, Haixia
    Sun, Xiaofei
    Zhang, Yizhuo
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [26] New insights into the anti-PD-L1 and anti-PD-1 reagents in cancer therapy
    Chen, Cheng
    Huang, Jian-An
    EUROPEAN JOURNAL OF INFLAMMATION, 2016, 14 (01) : 61 - 65
  • [27] Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
    Swaika, Abhisek
    Hammond, William A.
    Joseph, Richard W.
    MOLECULAR IMMUNOLOGY, 2015, 67 (02) : 4 - 17
  • [28] Systemic treatment with anti-PD-1 antibody nivolumab in combination with vaccine therapy in advanced pancreatic cancer
    Nesselhut, Jan
    Marx, Dagmar
    Lange, Hans
    Regalo, Goncalo
    Cillien, Nicole
    Chang, Raymond Y.
    Nesselhut, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
    Lipson, Evan J.
    Sharfman, William H.
    Drake, Charles G.
    Wollner, Ira
    Taube, Janis M.
    Anders, Robert A.
    Xu, Haiying
    Yao, Sheng
    Pons, Alice
    Chen, Lieping
    Pardoll, Drew M.
    Brahmer, Julie R.
    Topalian, Suzanne L.
    CLINICAL CANCER RESEARCH, 2013, 19 (02) : 462 - 468
  • [30] Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model
    Niwa, Hiroki
    Nakamura, Toru
    Kushiya, Hiroki
    Kuraya, Tomotaka
    Inoko, Kazuho
    Inagaki, Akihito
    Suzuki, Tomohiro
    Sasaki, Katsunori
    Tsuchikawa, Takahiro
    Hiraoka, Kei
    Shichinohe, Toshiaki
    Hatanaka, Yutaka
    Jolly, Douglas J.
    Kasahara, Noriyuki
    Hirano, Satoshi
    CANCER GENE THERAPY, 2024, 31 (09) : 1390 - 1401
12345